Edwards Lifesciences Corp (EW)
65.84
+0.09
(+0.14%)
USD |
NYSE |
Nov 07, 16:00
65.25
-0.59
(-0.90%)
Pre-Market: 20:00
Edwards Lifesciences Revenue (TTM): 6.600B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.600B |
| June 30, 2024 | 6.489B |
| March 31, 2024 | 6.398B |
| December 31, 2023 | 6.260B |
| September 30, 2023 | 5.347B |
| June 30, 2023 | 5.422B |
| March 31, 2023 | 5.501B |
| December 31, 2022 | 5.382B |
| September 30, 2022 | 5.364B |
| June 30, 2022 | 5.355B |
| March 31, 2022 | 5.357B |
| December 31, 2021 | 5.232B |
| September 30, 2021 | 5.094B |
| June 30, 2021 | 4.925B |
| March 31, 2021 | 4.474B |
| December 31, 2020 | 4.386B |
| September 30, 2020 | 4.369B |
| June 30, 2020 | 4.322B |
| March 31, 2020 | 4.484B |
| December 31, 2019 | 4.348B |
| September 30, 2019 | 4.152B |
| June 30, 2019 | 3.964B |
| March 31, 2019 | 3.821B |
| December 31, 2018 | 3.723B |
| September 30, 2018 | 3.634B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.548B |
| March 31, 2018 | 3.447B |
| December 31, 2017 | 3.435B |
| September 30, 2017 | 3.314B |
| June 30, 2017 | 3.232B |
| March 31, 2017 | 3.150B |
| December 31, 2016 | 2.964B |
| September 30, 2016 | 2.867B |
| June 30, 2016 | 2.743B |
| March 31, 2016 | 2.601B |
| December 31, 2015 | 2.494B |
| September 30, 2015 | 2.441B |
| June 30, 2015 | 2.432B |
| March 31, 2015 | 2.391B |
| December 31, 2014 | 2.323B |
| September 30, 2014 | 2.241B |
| June 30, 2014 | 2.129B |
| March 31, 2014 | 2.071B |
| December 31, 2013 | 2.046B |
| September 30, 2013 | 2.02B |
| June 30, 2013 | 1.972B |
| March 31, 2013 | 1.937B |
| December 31, 2012 | 1.900B |
| September 30, 2012 | 1.819B |
| June 30, 2012 | 1.784B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.322B
Minimum
Jun 2020
6.600B
Maximum
Sep 2024
5.255B
Average
5.351B
Median
Revenue (TTM) Benchmarks
| Teleflex Inc | 3.026B |
| Becton Dickinson & Co | 19.83B |
| NeuroOne Medical Technologies Corp | 3.922M |
| SINTX Technologies Inc | 1.438M |
| Nutriband Inc | 1.804M |